Detalhe da pesquisa
1.
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells.
Immunity
; 53(4): 805-823.e15, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33053330
2.
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 387(17): 1557-1568, 2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36094839
3.
Circulating tumour cells predict recurrences and survival in head and neck squamous cell carcinoma patients.
Cell Mol Life Sci
; 81(1): 233, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38780775
4.
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 25(5): 572-587, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38561010
5.
Lurbinectedin in small cell lung cancer: real-world experience of a multicentre national early access programme.
Intern Med J
; 2024 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369719
6.
Nutrition outcomes and treatment toxicities in patients with head and neck cancer receiving helical intensity-modulated radiotherapy.
J Hum Nutr Diet
; 37(1): 182-192, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37737485
7.
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
Lancet Oncol
; 24(11): 1196-1205, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37875144
8.
Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment.
Br J Nutr
; 129(3): 406-415, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35152926
9.
The changing face of head and neck cancer: are patients with human papillomavirus-positive disease at greater nutritional risk? A systematic review.
Support Care Cancer
; 30(9): 7191-7204, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477809
10.
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 379(4): 341-351, 2018 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29863979
11.
Oral HPV16 DNA as a screening tool to detect early oropharyngeal squamous cell carcinoma.
Cancer Sci
; 111(10): 3854-3861, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32713038
12.
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Lancet
; 394(10212): 1915-1928, 2019 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31679945
13.
Evaluation of a speech pathology service delivery model for patients at low dysphagia risk during radiotherapy for HNC.
Support Care Cancer
; 28(4): 1867-1876, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31352509
14.
Radiotherapy for cutaneous head and neck cancer and parotid tumours: a prospective investigation of treatment-related acute swallowing and toxicity patterns.
Support Care Cancer
; 27(2): 573-581, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30019149
15.
The ENHANCES study: a randomised controlled trial of a nurse-led survivorship intervention for patients treated for head and neck cancer.
Support Care Cancer
; 27(12): 4627-4637, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30941580
16.
Randomised controlled trial of early prophylactic feeding vs standard care in patients with head and neck cancer.
Br J Cancer
; 117(1): 15-24, 2017 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28535154
17.
Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non-small cell lung cancer.
Lung Cancer
; 192: 107820, 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38763104
18.
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma.
J Immunother Cancer
; 12(3)2024 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38471711
19.
Enteral nutrition support and treatment toxicities in patients with head and neck cancer receiving definitive or adjuvant helical intensity-modulated radiotherapy with concurrent chemotherapy.
Head Neck
; 45(2): 417-430, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36433667
20.
Development and Validation of txSim: A Model of Advanced Lung Cancer Treatment in Australia.
Pharmacoeconomics
; 41(11): 1525-1537, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37357233